7PLL | pdb_00007pll

Structure of the murine cortactin C-SH3 domain in complex with a Pyk2 proline-rich ligand

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H TOCSY	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
2	2D 1H-1H NOESY	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
3	1H-15N HSQC	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
4	3D HNCACB	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
5	2D 1H-1H TOCSY	0.8 mM 2H,13C,15N cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	100% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
6	2D 1H-1H NOESY	0.8 mM 2H,13C,15N cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	100% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
7	2D 1H-1H COSY	0.8 mM 2H,13C,15N cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	100% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
8	3D 12C13C filtered-edited NOESY	0.8 mM 2H,13C,15N cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	100% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
9	2D 1H-1H TOCSY	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
10	2D 1H-1H NOESY	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
11	2D 1H-1H TOCSY	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	100% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
12	2D 1H-1H NOESY	0.8 mM cortactin C-terminal SH3 domain, 0.8 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	100% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700
13	2D 1H-1H TOCSY	0.5 mM Pyk2-PRR2 peptide, 30 mM sodium phosphate, 0.01 % w/v sodium azide	93% H2O/7% D2O	123 mM	6.5	1 atm	296	Bruker DRX700 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX700	700

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CNS	1.3	Brunger, Adams, Clore, Gros, Nilges and Read
2	structure calculation	TALOS+		Shen, Grishaev, Bax
3	chemical shift assignment	TopSpin	3.6.1	Bruker Biospin
4	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
5	peak picking	TopSpin	3.6.1	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.